MTOR and myeloid sarcoma: Given that glial cells contribute to the development and maintenance of pain hypersensitivity following nerve lesion (Ferrini and De Koninck, 2013), enhanced mTOR signaling may contribute to the persistent pain of MS through regulation of specific cellular activities.